Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
NCT00224393
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Primary Systemic Amyloidosis
Interventions
DRUG:
Enbrel
Sponsor
The Cleveland Clinic